Split History
ETFs Holding JAGX »    JAGX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Jaguar Health is a commercial stage pharmaceuticals company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal distress, including chronic, debilitating diarrhea. Co.'s wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human pharmaceuticals for the global marketplace from plants or plant products used in rainforest areas. Napo's marketed drug Mytesi (crofelemer 125 mg delayed-release tablets) is an oral botanical drug product approved for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. According to our JAGX split history records, Jaguar Health has had 3 splits.
JAGX split history picture
Jaguar Health (JAGX) has 3 splits in our JAGX split history database. The first split for JAGX took place on June 01, 2018. This was a 1 for 15 reverse split, meaning for each 15 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. JAGX's second split took place on June 07, 2019. This was a 1 for 7 reverse split, meaning for each 7 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 9.52380952380952 share position following the split. JAGX's third split took place on September 08, 2021. This was a 1 for 3 reverse split, meaning for each 3 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 9.52380952380952 share position pre-split, became a 3.17460317460317 share position following the split.

When a company such as Jaguar Health conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the JAGX split history from start to finish, an original position size of 1000 shares would have turned into 3.17460317460317 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Jaguar Health shares, starting with a $10,000 purchase of JAGX, presented on a split-history-adjusted basis factoring in the complete JAGX split history. JAGX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/13/2015
End date: 08/15/2022
Start price/share: $2,135.70
End price/share: $0.30
Dividends collected/share: $0.00
Total return: -99.99%
Average Annual Total Return: -70.53%
Starting investment: $10,000.00
Ending investment: $1.40
Years: 7.26
Date Ratio
06/01/20181 for 15
06/07/20191 for 7
09/08/20211 for 3
JAGX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

JNJ Split History
JUNO Split History
KALV Split History
KBIO Split History
KIDS Split History
KOOL Split History
LCAV Split History
LCI Split History
LH Split History
LIFE Split History

Also explore: JAGX shares outstanding history

Email EnvelopeFree JAGX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Root, Inc. (ROOT)
Mind Medicine Inc. (MNED)
Greenlane Holdings, Inc. (GNLN)
U.S. Well Services, Inc. (USWS)
Nutriband Inc. (NTRB)
Exela Technologies, Inc. (XELA)
Motus GI Holdings, Inc. (MOTS)
Cellectar Biosciences, Inc. (CLRB)
Synthetic Biologics, Inc. (SYN)
McEwen Mining Inc. (MUX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

JAGX Insider Buying

JAGX Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.